Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    16736026 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Terminated Second-line Therapy of Unresectable Cholangiocarcinoma by RADIOEMBOLIZATION
Condition: Cholestasis, Progressive Familial Intrahepatic 3
Intervention: Device: Yttrium microsphere injection

Study has passed its completion date and status has not been verified in more than two years.